文献速递肺结节与肺癌

人工智能软件在CT肺癌筛查中结节与癌症检测的系统评价

Software using artificial intelligence for nodule and cancer detection in CT lung cancer screening: systematic review of test accuracy studies.
PubMed 文献 · Thorax · 2024-10-16

结果显示,AI辅助阅读较人工阅读更快,灵敏度普遍提高(检出/分类可操作结节提高5%至20%,检出/分类恶性结节提高3%至15%),但特异度降低(正确检出/分类无可操作结节者降低7%至3%,正确检出/分类无恶性结节者降低8%至6%)。

要点

  • AI辅助阅读可提高肺癌筛查结节检出灵敏度,但特异度降低。
  • AI辅助阅读速度更快,但会增加假阳性及不必要的CT监测。
  • 所有纳入研究存在高偏倚风险及多重适用性问题。

核心结论

  • AI辅助肺癌筛查可能提高灵敏度,但增加假阳性结果和不必要的监测。

主要发现

  • 与人工阅读相比,AI辅助阅读更快,检出/分类可操作结节的灵敏度提高5%至20%,检出/分类恶性结节的灵敏度提高3%至15%。
  • AI辅助阅读正确检出/分类无可操作结节者的特异度降低7%至3%,正确检出/分类无恶性结节者的特异度降低8%至6%。
  • AI辅助倾向于将更多结节归入更高风险类别。

临床怎么用

  • 临床使用AI辅助阅读需警惕假阳性增加及不必要的监测,应结合具体情况解读结果。

局限性

  • 所有纳入研究存在高偏倚风险及多重适用性问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To examine the accuracy and impact of artificial intelligence (AI) software assistance in lung cancer screening using CT. METHODS: A systematic review of CE-marked, AI-based software for automated detection and analysis of nodules in CT lung cancer screening was conducted. Multiple databases including Medline, Embase and Cochrane CENTRAL were searched from 2012 to March 2023. Primary research reporting test accuracy or impact on reading time or clinical management was included. QUADAS-2 and QUADAS-C were used to assess risk of bias. We undertook narrative synthesis. RESULTS: Eleven studies evaluating six different AI-based software and reporting on 19 770 patients were eligible. All were at high risk of bias with multiple applicability concerns. Compared with unaided reading, AI-assisted reading was faster and generally improved sensitivity (+5% to +20% for detecting/categorising actionable nodules; +3% to +15% for detecting/categorising malignant nodules), with lower specificity (-7% to -3% for correctly detecting/categorising people without actionable nodules; -8% to -6% for correctly detecting/categorising people without malignant nodules). AI assistance tended to increase the proportion of nodules allocated to higher risk categories. Assuming 0.5% cancer prevalence, these results would translate into additional 150-750 cancers detected per million people attending screening but lead to an additional 59 700 to 79 600 people attending screening without cancer receiving unnecessary CT surveillance. CONCLUSIONS: AI assistance in lung cancer screening may improve sensitivity but increases the number of false-positive results and unnecessary surveillance. Future research needs to increase the specificity of AI-assisted reading and minimise risk of bias and applicability concerns through improved study design. PROSPERO REGISTRATION NUMBER: CRD42021298449.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Geppert J, Asgharzadeh A, Brown A, et al. Software using artificial intelligence for nodule and cancer detection in CT lung cancer screening: systematic review of test accuracy studies. Thorax. 2024. PMID: 39322406. doi:10.1136/thorax-2024-221662

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。